As Drug Marketing Laws Proliferate In States, PhRMA Rejects Federal Option
Executive Summary
State laws to restrict how pharmaceutical companies market their products to physicians are not yet so burdensome that industry is ready to support a federal scheme, Pharmaceutical Research and Manufacturers of America VP for Government Affairs Jan Faiks told the Food and Drug Law Institute's advertising and promotion conference Sept. 17
You may also be interested in...
ACCME Poses Four Conditions For Acceptable Industry-Supported CME
The Accreditation Council for Continuing Medical Education is seeking comments on stronger measures to define when industry can help fund physician CME without compromising its independence
ACCME Poses Four Conditions For Acceptable Industry-Supported CME
The Accreditation Council for Continuing Medical Education is seeking comments on stronger measures to define when industry can help fund physician CME without compromising its independence
Grassley, Kohl Retool Physician Gift Reporting Bill To Defuse Opposition
Sens. Chuck Grassley, R-Iowa, and Herb Kohl, D-Wis., plan to add a state pre-emption provision to their Physician Payments Sunshine Act as they try to attach it to a Medicare bill being written by the Finance Committee